<DOC>
	<DOC>NCT02792842</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of ART-123 for the prevention of cancer treatment related symptoms in patients with postoperative stage II / III colon cancer.</brief_summary>
	<brief_title>Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Main Diagnosed with stage II / III colon cancer Deemed to have undergone curative A (Cur A) surgery Planning to undergo postoperative adjuvant chemotherapy Main Have a history of hypersensitivity to any of the ingredients in thrombomodulin alfa (recombinant) Have any treatment history of systemic chemotherapy (including any drug in the clinical trial stage) or radiotherapy With active double cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>